Spectrum Pharma says ‘lucanthone’ could treat lung cancer
April 17th, 2008
Biopharmaceutical company Spectrum Pharmaceuticals, Inc., said this morning that preclinical data on lucanthone suggest the orally administered small molecule inhibitor of DNA repair could potentially be used for the treatment of lung cancer.